Why is Bandaram Pharma falling/rising?

As of 09-Jul, Bandaram Pharma Packtech Ltd's stock price is currently at 41.60, reflecting a decrease of 0.05, or 0.12%. The stock has been underperforming, having lost 0.69% over the last two days and showing a performance today that is 0.58% below its sector. Despite a strong one-year return of 29.64%, the company's recent financial results indicate weaknesses, such as a significant drop in net sales and low profitability metrics. Additionally, the stock's delivery volume has decreased by 49.06% compared to the five-day average, suggesting falling investor participation. While the stock has a very attractive valuation with a ROCE of 6.2, the high Debt to EBITDA ratio of 6.31 times raises concerns about its long-term fundamental strength.
In the broader market context, Bandaram Pharma's short-term performance of +3.92% over the past week significantly outpaces the Sensex's modest gain of +0.15%. However, the stock's year-to-date performance shows a decline of 6.31%, contrasting sharply with the Sensex's increase of 6.91%. This divergence indicates that while the stock has performed well in the past year relative to the market, recent trends suggest a potential shift in investor sentiment, likely influenced by the company's disappointing quarterly results and declining trading activity.